The Sceptor System (Becton Dickinson) was compared with an agar dilution method for antimicrobial susceptibility testing of veterinary clinical isolates. The results indicate that the Sceptor System may be used to test gram-positive and fastidious gram-negative bacteria.
In vitro antimicrobial susceptibility testing of clinical isolates is performed in order to assist medical personnel in proper drug selection. Traditionally, the disk agar diffusion method described by Bauer et al. (2) has been used in North American bacteriology laboratories because of its technical simplicity and reproducibility. The qualitative results derived from the disk diffusion technique attempt to correlate ically entered into a computer which calculates the MICs and adds the National Committee for Clinical Laboratory Standards (NCCLS) (13) (13) .
Antimicrobial agents were incorporated into Mueller-Hinton agar plates as described by Barry (1) . The range of antimicrobial dilutions tested was identical to those of the Sceptor gram-negative and gram-positive test panels (Tables  1 and 2 ). For trimethoprim-sulfamethoxazole, laked horse blood replaced calf blood (8) . The MICs were recorded and interpreted according to the NCCLS standards (13) . Categorical agreement classified the results as complete agreement, minor error (involving a moderately susceptible result), major error (resistant by the Sceptor System and susceptible by the reference method), and very major error (susceptible by the Sceptor System and resistant by the reference method).
The quality of the Sceptor panels and the agar dilution method was assessed by testing the following quality control strains: Escherichia coli ATCC 25922, Enterococcusfaecalis ATCC 29212, Pseudomonas aeruginosa ATCC 27853, and S. aureus ATCC 29213. The MICs were all within NCCLS limits (13) .
There was 88.3% complete agreement between the Sceptor System and agar dilution method for fastidious gramnegative bacteria (Table 1) . Gentamicin and neomycin resulted in only 73.3 and 66.7% complete agreement, respectively. In both cases, the majority of errors were minor and involved isolates from all species tested. Although the therapeutic relevance of the high number of minor errors is questionable, Sceptor System results from testing fastidious gram-negative bacteria with gentamicin and neomycin should be interpreted with caution.
Six isolates of P. haemolytica were susceptible to ampicillin when tested by the Sceptor System and resistant when tested by the agar dilution method. These strains produced P-lactamase, which was not induced in the Sceptor System ampicillin test wells. The use of Sceptor anaerobe broth instead of gram-negative broth may have influenced the production of this enzyme.
Testing gram-positive bacteria with the Sceptor System and the agar dilution method resulted in 95.7% complete agreement. There was less than 90% complete agreement when amikacin was tested. The errors were mainly minor and involved streptococci.
Approximately 60% of the gram-negative and 77% of the gram-positive bacteria were "off scale" with respect to the MIC dilutions tested. The large number of off-scale MIC results was expected, since the bacteria were selected from random clinical specimens and not for their antimicrobial characteristics. This may be significant because differences in MIC results can be masked when one or both MICs are off scale. Thornsberry (14) suggested that complete agreement of a new system be at least 90% and that the combined major and very major errors be less than 5%. The Sceptor System clearly met these guidelines when gram-positive bacteria were tested ( 
